---
title: "Here's How Much $100 Invested In Cytokinetics 10 Years Ago Would Be Worth Today"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295042575.md"
description: "Cytokinetics (NASDAQ:CYTK) has outperformed the market over the past decade with an annualized return of 20.46%. A $100 investment made ten years ago would now be worth $657.08, based on a current stock price of $78.85. The company currently holds a market capitalization of $10.71 billion."
datetime: "2026-08-05T23:30:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295042575.md)
  - [en](https://longbridge.com/en/news/295042575.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295042575.md)
generator: "portal-rs"
---

# Here's How Much $100 Invested In Cytokinetics 10 Years Ago Would Be Worth Today

Cytokinetics (NASDAQ:CYTK) has outperformed the market over the past 10 years by 7.02% on an annualized basis producing an average annual return of 20.46%. Currently, Cytokinetics has a market capitalization of $10.71 billion.

**Buying $100 In CYTK:** If an investor had bought $100 of CYTK stock 10 years ago, it would be worth **$657.08** today based on a price of $78.85 for CYTK at the time of writing.

### Cytokinetics’s Performance Over Last 10 Years

![comp_fig](https://imageproxy.pbkrs.com/https://cdn.benzinga.com/files/images/story/2026/08/05/706e9b8acf9190b3919ff5568a311d8d.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg)

Finally -- what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

*This article was generated by Benzinga's automated content engine and reviewed by an editor.*

### Related Stocks

- [CYTK.US](https://longbridge.com/en/quote/CYTK.US.md)

## Related News & Research

- [Top Cytokinetics Executive Makes Attention-Grabbing Move With Insider Stock Sale](https://longbridge.com/en/news/296290252.md)
- [Will MYQORZO Traction Amid Weaker Q2 2026 Results Change Cytokinetics' (CYTK) Narrative](https://longbridge.com/en/news/296006872.md)
- [Cytokinetics EVP R&D Malik Fady Ibraham disposes of 3,500 common shares for $265,370](https://longbridge.com/en/news/296267986.md)
- [Here's How Much $100 Invested In EnerSys 5 Years Ago Would Be Worth Today](https://longbridge.com/en/news/296509562.md)
- [Here's How Much $100 Invested In Applied Materials 15 Years Ago Would Be Worth Today](https://longbridge.com/en/news/296369921.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**